Imexhs Ltd · ASX:IME
Imexhs — H1 FY26 Earnings Presentation
30 slides from Imexhs's earnings presentation, Sep 2, 2026
Slide 1: H1 FY26 Results
H1 FY26 Results IMEXHS Limited (ASX: IME) 2 September 2026
Slide 2: The radiology of the future now running in production
01 The radiology of the future now running in production
Slide 3: One company, two businesses
02 One company, two businesses Two businesses, one purpose: to widen access to medical imaging expertise. Software Radiology Services Cloud-based medical imaging software — RIS, PACS, Outsourced radiology, teleradiology, outpatient clinics universal viewer and, since April 2026, proprietary AI and m
Slide 4: The data behind the agents
03 The data behind the agents Our agents are trained on proprietary workflow data from our own radiology operation Users of the patient portal 2.9M up 66% pcp Partners 47 up from 25 pcp Proprietary AI agents 8
Slide 5: IMEXHS global presence
04 IMEXHS global presence Our certifications reaffirm our dedication to excellence across multiple geographies. ✓ ISO 27001 certified — Aquila+ platform and R&D process.
Slide 6: The half in review
05 The half in review 1 2 3 From launch to production Earnings ahead of plan Execution still uneven The agentic platform launched in April Underlying EBITDA improved materially New software ARR relied on a single and by 30 June was operating in a live on the prior corresponding period — large public
Slide 7: 1H FY26 financial highlights
06 1H FY26 financial highlights Sales Revenue Annual Recurring Underlying Revenue (ARR) EBITDA2 Up 17% yoy $16.0m Up 12% yoy $36.8m 311% vs pcp $1.27m Up 13% on a constant Flat on a constant currency basis1 currency basis1 Cash Debt $2.0m vs $0.5m at 31 $0.25m vs $3.3m at 31 December 2025 December 2
Slide 8: 1H FY26 business unit results
07 1H FY26 business unit results $M Software Radiology Corporate Total 1H FY26 Revenue 4.8 11.2 - 16.0 Underlying EBITDA 0.8 1.1 (0.6) 1.3 ARR 11.8 25.0 - 36.8 Software primarily relates to sales of IMEXHS Radiology includes RIMAB along with other services Enterprise and growing IMEXHS Cloud busines
Slide 9: Progress in ARR
08 Progress in ARR ARR AS AT 30 JUNE 2026 $36.8m, up 12% vs 30 Jun 2025: $11.8m from Software, $25m from Radiology services (1) Constant currency basis assumes that historical results at each year end are converted at the 30 Jun-26 exchange rate. This removes the impact of changes in currency rates
Slide 10: Contracted, not yet billing
09 Contracted, not yet billing Signed revenue and billing revenue are not the same thing. Not yet billing vs 31-Dec-25 vs 30-Jun-25 12% of ARR $4.40m from $1.68m +163% from $2.14m +106% at 30-Jun-26 H1 build-up YoY growth Backlog by segment (30-Jun-2026) Segment ARR ($M) % of bucket IMEXHS Radiology
Slide 11: Agentic AI radiology of the future
10 Agentic AI radiology of the future Scheduling: Books the appointment Triage: Surveys: Prioritises Suggests survey urgent studies images Orchestration: Quality: Coordinates the Checks workflow consistency Display: Reporting: Sets the reading Structures layout the report Detection: Flags findings i
Slide 12: Strategic Realignment — Five Priorities
11 Strategic Realignment — Five Priorities AI-First Product Strategy 1 Embed AI agents progressively across the radiology workflow. Product & Tech Consolidation 2 Standardised, modular and cloud-native Aquila+ platform. Protect & Expand Installed Base 3 Retention, Aquila+ migration, satisfaction, up
Slide 13: The agentic AI platform
12 The agentic AI platform Eight proprietary agents. One live public hospital network.
Slide 14: Why now
13 Why now Imaging demand is compounding. The Our approach radiologist workforce is not. We rebuilt the workflow around agents that operate inside the process itself, resolving Delay, error and cost do not concentrate in the reading itself. operational tasks autonomously. That is what They concentra
Slide 15: Eight agents across the full workflow
14 Eight agents across the full workflow 1 Scheduling Reads medical orders and insurance authorisations, applies 2 Prioritisation each institution’s rules and books appointments automatically. Assigns study priority from clinical data using a self-learning DEVELOPMENT COMPLETE medical dictionary, su
Slide 16: Eight agents across the full workflow
15 Eight agents across the full workflow 5 Reading co-pilot 6 Hanging protocols Enhances dictated reports, incorporates patient and study context and suggests report templates at the point of reading. Exclusive to Applies the correct image-display layout for each study, Aquila+. Multi-language trans
Slide 17: Why it compounds
16 Why it compounds 1 Cross-sell inside the installed base 2 Displacement in procurement 569 installations already contracted, integrated and trained. Full-workflow automation changes what we are compared Each new agent is a product with no new customer to against. Tenders decided on operational out
Slide 18: Software business highlights
17 Software business highlights SOFTWARE ARR ENTERPRISE WINS PARTNERS CHANNEL → Zacatecas public tender, Mexico — → 47 partners in 13 LATAM countries, from 25 a → $11.8m ARR and $4.8m revenue $384,000 NARR. year ago. at 1H FY26. → Pulso Salud, Peru — $163,000 NARR. → 75% of software NARR in H1. → Dr
Slide 19: Software product
18 Software product Platform progress Delivered value → New Web Viewer advanced materially, with the hanging- → Aquila+ commercially live; all new contracts deploy on the protocol agent embedded. platform. → Visibility controls for AI-generated images, supporting safer → ISO 27001 certification held
Slide 20: Partner Programme
19 Partner Programme The primary route to market — and now proven at enterprise scale. Partners 47 +22 vs pcp LATAM countries 13 Software NARR from Partners 75% Colombia (15 partners), Mexico (9) and Ecuador (6) are the most developed markets. Two partners were onboarded in the second quarter. Both
Slide 21: Commercial execution
20 Commercial execution One transformational win. Not yet a repeatable engine. Where we fell short What is already in place → New software ARR written in the half: $1.1m. → Enhanced lead scoring and stage-gate qualification. → Our average deal size moved sharply and then settled into → Tighter forec
Slide 22: Radiology services — RIMAB
21 Radiology services — RIMAB Business model Operating footprint → Outsourcing. → Teleradiology. → Outpatient clinics. 38 sites · 157 radiologists · 90,000 procedures per month → Mobile units. Financial snapshot Technology integration → Revenue $11.2m → ARR $25m Proprietary AI agents built by IMEXHS
Slide 23: Colombia — operating environment
22 Colombia — operating environment The election is decided. The liquidity is not yet unwound. Healthcare-sector liquidity pressure, driven by delays in government payments to healthcare insurers, persisted through the half and through the election period, which concluded with a runoff in June 2026.
Slide 24: Leadership and governance
23 Leadership and governance Mr Fabio Carrillo, appointed effective 1 August 2026. A Chartered Accountant with a Bachelor of → Chief Financial Officer Commerce (Professional Accounting) from Macquarie University and 20 years in public practice across tax and business advisory. Supported by a strengt
Slide 25: Priorities for 2H FY26
24 Priorities for 2H FY26 Software Business Radiology Services → Convert large-deal capability into repeatable, → Collections and working capital as the first-order priority. territory-balanced NARR. → Protect embedded margin. → Commence billing on the contracted software book. → Commence the Sanita
Slide 26: FY26 guidance
25 FY26 guidance The Company expects to achieve the following for FY26: → Revenue in the range $31.4 m to $33.7m - up 8% to 16% vs prior year. → Underlying EBITDA in the range $2.4m to $2.7m – up 48% to 66% vs prior year.
Slide 27: THANK YOU
THANK YOU
Slide 28: Q&A
Q&A
Slide 29: Disclaimer
Disclaimer The information contained in this Presentation or subsequently provided to the Recipient of this Presentation, whether orally or in writing by or on behalf of ImExHS Limited or its respective employees, agents or consultants (“Information”) is provided to the Recipient on the terms and co
Slide 30: 1H FY26 Results
1H FY26 Results 2 September 2026